Insider Transactions in Q2 2025 at Artivion, Inc. (AORT)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 27
2025
|
Jean F Holloway SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
8,748
-4.67%
|
$253,692
$29.0 P/Share
|
May 23
2025
|
Anthony B. Semedo Director |
SELL
Open market or private sale
|
Direct |
2,600
-7.29%
|
$72,800
$28.47 P/Share
|
May 22
2025
|
Marna P Borgstrom Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+11.41%
|
-
|
May 22
2025
|
Anthony B. Semedo Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+13.09%
|
-
|
May 22
2025
|
Jon W Salveson Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+4.65%
|
-
|
May 22
2025
|
Thomas F Ackerman Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+4.05%
|
-
|
May 22
2025
|
Daniel J Bevevino Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+4.04%
|
-
|
May 22
2025
|
Jeffrey H Burbank Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+10.52%
|
-
|
May 22
2025
|
Elizabeth A Hoff Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+16.77%
|
-
|
May 22
2025
|
James Bullock Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,325
+8.44%
|
-
|
May 21
2025
|
Jean F Holloway SVP, General Counsel |
SELL
Open market or private sale
|
Direct |
9,926
-5.03%
|
$287,854
$29.0 P/Share
|
May 09
2025
|
Marshall S. Stanton SVP, Clinical & MD Affair |
SELL
Open market or private sale
|
Direct |
10,548
-4.66%
|
$305,892
$29.13 P/Share
|